RECRUITING

Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)

Description

The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis. Finding the genes that cause pulmonary fibrosis is the first step at developing better methods for early diagnosis and improved treatment for pulmonary fibrosis. The overall hypothesis is that inherited genetic factors predispose individuals to develop pulmonary fibrosis.

Study Overview

Study Details

Study overview

The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis. Finding the genes that cause pulmonary fibrosis is the first step at developing better methods for early diagnosis and improved treatment for pulmonary fibrosis. The overall hypothesis is that inherited genetic factors predispose individuals to develop pulmonary fibrosis.

Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)

Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)

Condition
Idiopathic Pulmonary Fibrosis
Intervention / Treatment

-

Contacts and Locations

Aurora

University of Colorado Denver, Aurora, Colorado, United States, 80045

Denver

National Jewish Health and University of Colorado Denver, Denver, Colorado, United States, 80206

Nashville

Vanderbilt University, Nashville, Tennessee, United States, 37232

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Two or more family members with a clinical diagnosis of Idiopathic Pulmonary Fibrosis (IPF) or Idiopathic Interstitial Pneumonia (IIP)
  • * Additional family members may be eligible to participate if two family members are suspected of or diagnosed as having Idiopathic Pulmonary Fibrosis (IPF) or Idiopathic Interstitial Pneumonia (IIP)
  • * Individuals whose pulmonary fibrosis is due to a known cause rather than idiopathic
  • * Individuals whose pulmonary fibrosis is due to a broader genetic syndrome

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

National Jewish Health,

David A. Schwartz, MD, PRINCIPAL_INVESTIGATOR, University of Colorado Denver; National Jewish Health

Study Record Dates

2025-06